Article
Characterizing Longitudinal Molecular Changes in ctDNA in Patients with Metastatic Castration-Resistant Prostate Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 May 2026
Jani Chinmay T, Tran Eli, Zhang Nicole, Tsai Jill, Dong Jianjie, Bucheit Leslie, Pan Elizabeth, Panian Justine, Chen Yu-Wei, McKay Rana R
Abstract excerpt
PURPOSE: Circulating tumor DNA (ctDNA) next-generation sequencing complements tissue-based testing and offers insights into prognosis, treatment selection, and tumor evolution. Despite advances in metastatic castration-resistant prostate cancer (mCRPC) therapies, resistance remains a challenge. This real-world study evaluates longitudinal ctDNA changes following systemic treatments. EXPERIMENTAL DESIGN: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
